Testing and contact tracing are essential for controlling the COVID-19 pandemic. Nine months into the pandemic, countries around the world are struggling to keep up with testing needs. As many countries face ongoing waves of infections, demand for high-quality diagnostic tests keeps growing. With more than 1,000 COVID-19 tests in development or on the market, spanning different technology platforms with varying levels of performance and availability, it is highly challenging for decision-makers to select which tests to purchase and use.
Developed by a multi-disciplinary team at PATH, a global public health nonprofit dedicated to health equity, the new COVID-19 diagnostics dashboard aggregates and visualizes publicly available information about the development, supply, and performance of COVID-19 diagnostic tests on or entering the market. This Tableau-based tool has been designed to help governments, procurement agencies, and other stakeholders to support data-driven selection and procurement decisions.
Diagnostics on the dashboard can be searched by platform, test performance, regulatory status, country of origin, and commercial availability, making the complex COVID-19 diagnostics marketplace more accessible and available to all.